Alps Advisors Inc Neurocrine Biosciences Inc Transaction History
Alps Advisors Inc
- $14.1 Billion
- Q1 2024
A detailed history of Alps Advisors Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Alps Advisors Inc holds 2,506 shares of NBIX stock, worth $346,404. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,506
Previous 2,915
14.03%
Holding current value
$346,404
Previous $384,000
10.16%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
628Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.37 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$552 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$317 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$311 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...